Sign in
4

Changes in Ownership

BioXcel Therapeutics, Inc. Filed Acc 0001104659-22-034508

Options or other derivatives

  • Chief Medical Officer acquired 8,337 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

O'Neill Vincent · Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-03-14 Grant or award : show line 1 in the form Restricted Stock Units +8,337 8,337 D
Loading xslF345X03/tm229449-5_4seq1.xml…